St Phi Therapeutics

About:

Yizun Biotechnology is a cutting-edge immune cell therapy company that has developed many unique platform technologies.

Website: http://www.stphitherapeutics.com

Top Investors: Shenzhen Capital Group, Tao Capital Partners, Panacea Venture, Tailong Investment, Tasly Capital

Description:

Yizun Biotechnology is a cutting-edge immune cell therapy company that has developed many unique platform technologies, including solid tumor treatment and allogeneic universal cell therapy.